Welbourne T, Weber M, Bank N
J Clin Invest. 1972 Jul;51(7):1852-60. doi: 10.1172/JCI106987.
The effect of acute changes in the delivery rate of glutamine to the kidney on urinary ammonium excretion was studied in man. Healthy subjects and patients with intrinsic renal disease were studied under three different acid-base conditions: unaltered acid-base balance; NH(4)Cl-induced acidosis; and NaHCO(3)-induced alkalosis. Anhydrous L-glutamine was administered orally in a single dose of 260 mmoles during each of these three acid-base states. We found that endogenous venous plasma glutamine concentration fell during acidosis and rose during alkalosis in both healthy subjects and patients with renal disease. In healthy subjects, orally administered glutamine raised plasma glutamine concentration markedly over a 2-3 hr period. This was accompanied by an increase in urinary ammonium excretion and a rise in urine pH under normal acid-base conditions and during metabolic acidosis. No increase in ammonium excretion occurred when glutamine was administered during metabolic alkalosis in spite of an equivalent rise in plasma glutamine concentration. In patients with renal disease, endogenous venous plasma glutamine concentration was lower than in healthy subjects, perhaps as a result of mild metabolic acidosis. Acute oral glutamine loading failed to increase urinary ammonium excretion significantly during either unaltered acid-base conditions or after NH(4)Cl-induced acidosis, even though plasma glutamine rose as high as in healthy subjects. We conclude from these observations that glutamine delivery to the kidney is a rate-limiting factor for ammonium excretion in healthy subjects, both before and after cellular enzyme adaptation induced by metabolic acidosis. In contrast, in patients with renal disease, glutamine delivery is not rate-limiting for ammonium excretion. Presumably other factors, such as surviving renal mass and the activity of intracellular enzymes necessary for ammonia synthesis limit ammonium excretion in these patients.
在人体中研究了谷氨酰胺向肾脏输送速率的急性变化对尿铵排泄的影响。在三种不同的酸碱状态下对健康受试者和患有内在性肾病的患者进行了研究:酸碱平衡未改变;氯化铵诱导的酸中毒;以及碳酸氢钠诱导的碱中毒。在这三种酸碱状态下,均单次口服260毫摩尔无水L-谷氨酰胺。我们发现,无论是健康受试者还是肾病患者,酸中毒时内源性静脉血浆谷氨酰胺浓度下降,碱中毒时则上升。在健康受试者中,口服谷氨酰胺在2 - 3小时内使血浆谷氨酰胺浓度显著升高。在正常酸碱条件下和代谢性酸中毒期间,这伴随着尿铵排泄增加和尿液pH值升高。尽管血浆谷氨酰胺浓度有同等程度的升高,但在代谢性碱中毒期间给予谷氨酰胺时,铵排泄并未增加。在患有肾病的患者中,内源性静脉血浆谷氨酰胺浓度低于健康受试者,这可能是轻度代谢性酸中毒的结果。即使血浆谷氨酰胺升高至与健康受试者相同的水平,在酸碱平衡未改变的情况下或氯化铵诱导的酸中毒后,急性口服谷氨酰胺负荷也未能显著增加尿铵排泄。我们从这些观察结果得出结论,在代谢性酸中毒诱导细胞酶适应之前和之后,向肾脏输送谷氨酰胺都是健康受试者铵排泄的限速因素。相比之下,在患有肾病的患者中,谷氨酰胺输送不是铵排泄的限速因素。据推测,其他因素,如存活的肾单位数量和氨合成所需的细胞内酶活性,限制了这些患者的铵排泄。